click below
click below
Normal Size Small Size show me how
PROSTATE CANCER
| Question | Answer | |
|---|---|---|
| Prostate cancer Risk Factors | Age, Gender, Ethnicity, Family History, AGENT ORANGE EXPOSURE, increases risk of death in AA males | |
| Prostate anatomy | Helps control urine flow Produces fluid component of semen Produces PSA and acid phosphate | |
| Prostate Cancer Screening | DRE (digital rectal exam) PSA Transrectal US (NOT DX) Biopsy (DIAGNOSTIC) | |
| THINGS THAT INCREASE PSA | BPH (prostate growing) Age Prostatits Ejaculation DRE | |
| THINGS THAT DECREASE PSA | Drugs: Finasteride, Dutasteride, Herbs?? Obesity | |
| Prostate Cancer S/Sx | decreased urinary stream Bladder/bowel incontinence urinary frequency (need to go often and cant) Hematuria (blood in urine) Bone pain Lower extremity numbness or weakness | |
| PCPT TRIAL | Finasteride 5mg vs placebo Finasteride decreases PC but showed no difference in overall survival Finasteride increased high grade PC compared to placebo making the cancer more aggressive (AD) | |
| REDUCE TRIAL | Dutasteride VS Placebo Dustasteride showed a 23% reduction compared to placebo | |
| COMBAT Trial | Dutasteride + Tamsulosin VS Tamsulosin 40% lower incidence of prostate cancer with dutasteride + tamsulosin alone | |
| ASCO Recommendation for prostate cancer | 5-AR inhibitors decrease but DO NOT eliminate risk for prostate cancer. MAIN IDEA: no difference in survival. | ADEs for 5-AR inhibitors: gynecomastia, ED, decreased libido, nausea, abdominal pain, asthenia, dizziness, flatulence, headache, rash, muscle weakness, teratogenicity |
| SELECT Trial | Selenium & Vitamin E Men only taking Vit E had a 17% increase risk in developing prostate cancer | DO NOT GIVE VITAMIN E ALONE TO AT RISK PATIENTS |
| Diagnosing Prostate Cancer | DRE, PSA, Transrectal US, US guided biopsy | NORMAL PSA = 0-3 ng/mL 3ng/mL - needs further eval >10 ng/mL - highly sus!! |
| GLEASON SCORE | grading system for evaluating architectural details of cancer cells 2-4 = BEST prognosis = 12% risk of spread 5-6 = Intermediate = 33% risk 7-10 = Worst = 61% risk | the higher the score the higher the risk of spread and the worse the cancer is |
| Recurrence Risk & Treatment (LN |